A high number of PD-L1 + CD14 + monocytes in peripheral blood is correlated with shorter survival in patients receiving immune checkpoint inhibitors

ConclusionIncrease in pretreatment expression levels of PD-L1 on CD14+ monocytes is associated with the OS of patients treated with immune checkpoint inhibitors. Further evaluation of large sample size and each specific cancer type might clarify the predictive role of PBMC in patients.
Source: Cancer Immunology, Immunotherapy - Category: Cancer & Oncology Source Type: research